Retraction: Activation of the AMP-Activated Protein Kinase (AMPK) by nitrated lipids in endothelial cells (PLoS ONE (2012) 7:2 (e31056) DOI: 10.1371/journal.pone.0031056);Activation of the AMP-activated protein kinase (AMPK) by nitrated lipids in endothelial cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Wu, Yong ^a,b   Dong, Yunzhou ^a   Song, Ping ^a   Zou, Ming Hui ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; HEME OXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; THREONINE; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NITRATION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; AORTA; BIOSYNTHESIS; CATTLE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; INTRACELLULAR SPACE; METABOLISM; NITROSATION; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AORTA; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CATTLE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SPACE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROSATION; OLEIC ACID; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 84857162367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0233408     Document Type: Erratum

References (60)

1. Ischiropoulos H, Beckman JS, (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111: 163-169.
2. Zou MH, Cohen R, Ullrich V, (2004) Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97.
3. Radi R, (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101: 4003-4008.
4. Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, et al. (2005) Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 280: 42464-42475.
5. Villacorta L, Zhang J, Garcia-Barrio MT, Chen XL, Freeman BA, et al. (2007) Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am J Physiol Heart Circ Physiol 293: H770-776.
6. Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, et al. (2008) Nitro-fatty acid formation and signaling. J Biol Chem 283 (23): 15515-9.
7. Lima ES, Di Mascio P, Rubbo H, Abdalla DS, (2002) Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochemistry 41: 10717-10722.
8. Halliwell B, (2000) Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res 47: 410-418.
9. Lima ES, Di Mascio P, Abdalla DS, (2003) Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins. J Lipid Res 44: 1660-1666.
10. Hayashi K, Noguchi N, Niki E, (1995) Action of nitric oxide as an antioxidant against oxidation of soybean phosphatidylcholine liposomal membranes. FEBS Lett 370: 37-40.
11. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168.
12. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
13. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, et al. (1995) 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270: 27186-27191.
14. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al. (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28.
15. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, et al. (2005) The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066.
16. Zou MH, Wu Y, (2008) AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 35: 535-545.
17. Hattori Y, Suzuki K, Hattori S, Kasai K, (2006) Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47: 1183-1188.
18. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, et al. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887.
19. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, et al. (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13: 2004-2008.
20. Ziello JE, Jovin IS, Huang Y, (2007) Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 80: 51-60.
21. Taylor CT, (2008) Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 409: 19-26.
22. Wenger RH, (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. Faseb J 16: 1151-1162.
23. Brahimi-Horn C, Mazure N, Pouyssegur J, (2005) Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17: 1-9.
24. Wang J, Semenza G, Sylvester JT, Shimoda LA, (2005) HIF-1 regulates hypoxic-induction of canonical transient receptor potential (TRPC) channels in pulmonary arterial smooth muscle cells. Faseb J 19: A1278.
25. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19.
26. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, et al. (2002) Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 277: 32552-32557.
27. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, et al. (2006) AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281-1287.
28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605.
29. Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, et al. (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91: 375-381.
30. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, et al. (2004) Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766.
31. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, et al. (1998) Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077.
32. Willis D, Moore AR, Frederick R, Willoughby DA, (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87-90.
33. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ, (1997) Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216.
34. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, et al. (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135.
35. Poss KD, Tonegawa S, (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919-10924.
36. Soares MP, Brouard S, Smith RN, Bach FH, (2001) Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 184: 275-285.
37. Motterlini R, Foresti R, Intaglietta M, Winslow RM, (1996) NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270: H107-114.
38. Polte T, Oberle S, Schroder H, (1997) The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase. J Mol Cell Cardiol 29: 3305-3310.
39. Deramaudt BM, Braunstein S, Remy P, Abraham NG, (1998) Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127.
40. Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, et al. (2006) Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci U S A 103: 4299-4304.
41. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, et al. (2011) Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300: H84-93.
42. Sutter CH, Laughner E, Semenza GL, (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A 97: 4748-4753.
43. Dulak J, Deshane J, Jozkowicz A, Agarwal A, (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231-241.
44. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, et al. (2007) Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 104: 5109-5114.
45. Aley PK, Porter KE, Boyle JP, Kemp PJ, Peers C, (2005) Hypoxic modulation of Ca2+ signaling in human venous endothelial cells. Multiple roles for reactive oxygen species. J Biol Chem 280: 13349-13354.
46. Stahmann N, Woods A, Carling D, Heller R, (2006) Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 26: 5933-5945.
47. da Silva CG, Jarzyna R, Specht A, Kaczmarek E, (2006) Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells: involvement of P2 receptors and adenosine transporters. Circ Res 98: e39-47.
48. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, et al. (2008) Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 200: 28-36.
49. Zou MH, Wu Y, (2008) AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol 34: 35 (5-6): 535-45.
50. Forstermann U, Munzel T, (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714.
51. Gorczynski MJ, Huang J, King SB, (2006) Regio- and stereospecific syntheses and nitric oxide donor properties of (E)-9- and (E)-10-nitrooctadec-9-enoic acids. Org Lett 8: 2305-2308.
52. Moriel P, Pereira IR, Bertolami MC, Abdalla DS, (2001) Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia? Free Radic Biol Med 30: 318-326.
53. Nagata D, Mogi M, Walsh K, (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278: 31000-31006.
54. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, et al. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309.
55. Ruderman NB, Cacicedo JM, Itani S, Yagihashi N, Saha AK, et al. (2003) Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans 31: 202-206.
56. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, et al. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 277: 32571-32577.
57. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, et al. (2001) Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894.
58. Davis BJ, Xie Z, Viollet B, Zou MH, (2006) Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55: 496-505.
59. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J, (1999) PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19: 546-551.
60. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG, et al. (2004) Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279: 43940-43951.